A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Clinical trial NCT03981822 · COMPLETED
Trial details
- NCT number
- NCT03981822
- Sponsor
- Verrica Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2020-05-21
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.